Compounds > baclofen
Page last updated: 2024-10-23

baclofen and Experimental Hepatoma

baclofen has been researched along with Experimental Hepatoma in 1 studies

Research Excerpts

ExcerptRelevanceReference
" In this study, we investigated the antitumor effect of the GABABR agonist baclofen (Bac) on growth of human hepatocellular carcinoma (HCC) in vitro and in vivo."7.74Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. ( Chen, F; Huang, W; Wang, T, 2008)
" In this study, we investigated the antitumor effect of the GABABR agonist baclofen (Bac) on growth of human hepatocellular carcinoma (HCC) in vitro and in vivo."3.74Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. ( Chen, F; Huang, W; Wang, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, T1
Huang, W1
Chen, F1

Other Studies

1 other study available for baclofen and Experimental Hepatoma

ArticleYear
Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo.
    Life sciences, 2008, Feb-27, Volume: 82, Issue:9-10

    Topics: Animals; Baclofen; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cycl

2008